Ardelyx, Inc. discovers, develops, and commercializes medicines to treat unmet medical needs in the United States and internationally. The company offers IBSRELA, a minimally absorbed small molecule therapy for the treatment of patients with irritable bowel syndrome with constipation; and XPHOZAH...
84 insider purchases on record · latest filing 2026-02-20.
Insiders have also filed 466 sale transactions at ARDX.